Exhibit 99.1

 

 

21ST CENTURY ONCOLOGY HOLDINGS, INC.

 

Contact:

Bryan J. Carey

President and CFO

239-931-7285

BCarey@rtsx.com

 

Investors:

Nick Laudico

The Ruth Group

646-536-7030

nlaudico@theruthgroup.com

 

21ST CENTURY ONCOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS

 

Fourth Quarter 2013 Highlights:

 

·                  Total company pro forma revenues of $209.2 million, up 23.9% year-over-year, including $5.8 million in pro forma contribution from acquisitions; excluding acquisitions, revenues grew 20.5% year-over-year

·                  Total domestic Radiation Oncology cases completed increased 12.3%

·                  Domestic same market treatments per day increased 7.9%

·                  International cases increased 7.0%

·                  Pro Forma Adjusted EBITDA of $27.2 million

·                  Completed acquisition of OnCure Holdings, Inc. (“Oncure”) on October 25, adding significant scale and opportunity for long term revenue growth and operating synergies

·                  Transitioned corporate identity to 21st Century Oncology brand, recognized globally for high quality integrated cancer care (“ICC”) services

·                  Acquired strategically located radiation therapy facility with certificate of need (“CON”) in Roanoke Rapids, NC; upgrading with advanced technologies and clinical pathways

·                  Entered strategic partnership with ProHealth Care Associates, LLP, the largest physician group practice in the metropolitan New York area, to operate an ICC  practice in Riverhead, NY as well as jointly pursue additional strategic opportunities

 

Full Year 2013 Highlights:

 

·                  Total company pro forma revenues of $845.3 million, up 20.7% year-over-year, including $108.8 million in pro forma contribution from acquisitions; excluding acquisitions, revenues grew 6.1% year-over-year

·                  Total domestic Radiation Oncology cases completed increased 13.1%

·                  Domestic same market treatments per day increased 4.3%

·                  International cases increased 5.7%

·                  Pro Forma Adjusted EBITDA of $118.6 million

 

FORT MYERS, FL, February, 19, 2014 — 21

st Century Oncology Holdings, Inc. (“21st Century Oncology”, “21C” or the “Company”), the leading global, physician-led provider of

 


The following information was filed by 21St Century Oncology Holdings, Inc. (RTSX) on Wednesday, February 19, 2014 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate 21St Century Oncology Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 21St Century Oncology Holdings, Inc..

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account